FDA.reportPublic FDA data

SODIUM STEARYL FUMARATE

Substance profile for UNII 7CV7WJK4UI, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM STEARYL FUMARATE
Structure render from PubChem CID 23665634

Substance Identity#

UNII
7CV7WJK4UI
Preferred term
SODIUM STEARYL FUMARATE
Registry number
4070-80-8
EC number
223-781-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C22H39O4.Na
Chemical structure for SODIUM STEARYL FUMARATE
Structure render from PubChem CID 23665634

Chemical And Database Identifiers#

InChIKey
STFSJTPVIIDAQX-LTRPLHCISA-M
SMILES
[Na+].CCCCCCCCCCCCCCCCCCOC(=O)\C=C\C([O-])=O
RxCUI
1364936
PubChem
23665634
NCIt
C82292
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound23665634https://pubchem.ncbi.nlm.nih.gov/compound/23665634
PubChem InChIKey SearchSTFSJTPVIIDAQX-LTRPLHCISA-Mhttps://pubchem.ncbi.nlm.nih.gov/#query=STFSJTPVIIDAQX-LTRPLHCISA-M
RxNorm1364936https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1364936
NCI ThesaurusC82292https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C82292
FDA Substance Registration System7CV7WJK4UIhttps://precision.fda.gov/uniisearch/srs/unii/7CV7WJK4UI
European Community number223-781-1https://commonchemistry.cas.org/results?q=223-781-1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIFENOFIBRATE1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIKinray, LLC Omeprazole Drug Facts3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19921
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIMetaxalone Tablets3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIShopRite Omeprazole Delayed Release Tablets 20 mg Drug Facts2
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIKmart Corporation Omeprazole Drug Facts4
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDZA Brands, LLC Omeprazole Drug Facts4
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIHarmon Stores Inc. Omeprazole Drug Facts3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UILorazepam1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use Oxcarbazepine safely and effectively. See full prescribing information for Oxcarbazepine Tablets. Oxcarbazepine Tablets Initial U.S. Approval: 200014
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use OXCARBAZEPINE safely and effectively. See full prescribing information for OXCARBAZEPINE tablets. OXCARBAZEPINE tablets, for oral use Initial U.S. Approval: 20001
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use calcium acetate capsules safely and effectively. See full prescribing information for calcium acetate capsules. Calcium Acetate Capsules, 667 mg Initial U.S. Approval: 19901
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIBaby Teething Plus Tooth Support2
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UI0022ca14-9177-4fe9-90f3-1d67592d8d6c1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 19911
sodium stearyl fumarateINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use Montelukast sodium safely and effectively. See full prescribing information for Montelukast sodium. Montelukast sodium Tablets and Chewable Tablets Initial U.S. approval: 1998 --------- RECENT MAJOR CHANGES --------------- Warnings and Precautions Neuropsychiatric Events (5.4) 03/20131
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UI22c8c913-ee81-4e96-8306-013b44ec0fd42
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIFexofenadine HCl and Pseudoephedrine HCI ER Tablets USP 180240 mg1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOxcarbazepine Tablets1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets . Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19921
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIMetaxalone Tablets1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIFluvoxamine Maleate Tablets These highlights do not include all the information needed to use Fluvoxamine Maleate Tablets safely and effectively. See full prescribing information for Fluvoxamine Maleate Tablets. Fluvoxamine Maleate Tablets for oral administration Initial U.S. Approval: 19941
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use metoprolol succinate safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets USP for Oral Use Initial U.S. Approval: 19923
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral use. "Initial U.S. Approval:199220
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA ® (sitagliptin) Tablets Initial U.S. Approval: 20061
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UITRANDOLAPRIL TABLETS 7325 7326 7327 Rx only4
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use valacyclovir hydrochloride tablets safely and effectively. See full prescribing information for valacyclovir hydrochloride tablets. VALACYCLOVIR hydrochloride tablets, film-coated for oral use Initial U.S. Approval: 19951
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use metoprolol succinate extended-release tablets safely and effectively. See full prescribing information for metoprolol succinate extended-release tablets. Metoprolol Succinate Extended-Release Tablets, USP for Oral Use INITIAL U.S. APPROVAL: 19925
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 20072
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use fluvoxamine maleate tablets USP safely and effectively. See full prescribing information for fluvoxamine maleate tablets USP. Fluvoxamine maleate tablets USP, for oral use Initial U.S. Approval: 19944
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 19911
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIFelodipine ER Tabs2
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOpana ER 20 mg These highlights do not include all the information needed to use OPANA® ER safely and effectively. See full prescribing information for OPANA® ER. OPANA® ER (oxymorphone hydrochloride) Extended-Release tablets, CII Initial U.S. Approval: 19593
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use OPANA ER safely and effectively. See full prescribing information for OPANA ER. OPANA ER (Oxymorphone Hydrochloride) Extended-Release Tablets, CII Initial U.S. Approval: 2009 ® ® ®2
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOmeprazole Delayed Release Tablets, 20 mg3
sodium stearyl fumarateINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use AXERT ® safely and effectively. See full prescribing information for AXERT ® . AXERT (almotriptan malate) Tablets for Oral Use Initial U.S. Approval: 20012
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir/ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir/ritonavir) Solution for Oral use Initial U.S. Approval: 20001
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts2
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts2
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use valacyclovir hydrochloride tablets safely and effectively. See full prescribing information for valacyclovir hydrochloride tablets. VALACYCLOVIR hydrochloride tablets, film-coated for oral use Initial U.S. Approval: 19951
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
sodium stearyl fumarateINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use Montelukast sodium safely and effectively. See full prescribing information for Montelukast sodium. Montelukast sodium Tablets and Chewable Tablets Initial U.S. approval: 19981
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
sodium stearyl fumarateINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use ZEGERID safely and effectively. See full prescribing information for ZEGERID. ZEGERID (omeprazole/sodium bicarbonate) Powder for Oral Suspension ZEGERID (omeprazole/sodium bicarbonate) Capsules Initial U.S. Approval: 20041
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20002
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UI16ed3ca8-c85c-4d06-9c4f-d5bbf344b12e1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use pravastatin sodium tablets USP safely and effectively. See full prescribing information for pravastatin sodium tablets USP. PRAVASTATIN SODIUM tablets USP for oral use Initial U.S. Approval: 19912
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIMAVIK® (trandolapril tablets)2
sodium stearyl fumarateINACTIVE INGREDIENT7CV7WJK4UITARKA® (trandolapril/verapamil hydrochloride ER tablets)2
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS ® (raltegravir) Film-Coated Tablets, for oral use ISENTRESS ® (raltegravir) Chewable Tablets, for oral use Initial U.S. Approval: 20072
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use Trilipix safely and effectively. See full prescribing information for Trilipix. Trilipix (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 20081
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use Fluvoxamine Maleate Tablets safely and effectively. See full prescribing information for Fluvoxamine Maleate Tablets. Fluvoxamine Maleate Tablets, USP for oral administration Initial U.S. Approval: 19944
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOndansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UI5ca97412-1594-4a4e-b5e4-8593ffa1b2422
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIPrilosec OTC ® omeprazole magnesium delayed- release tablets 20.6 mg / acid reducer1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOPANA ® ER (Oxymorphone Hydrochloride) Extended-Release Tablets 5mg, 10mg, 20mg, and 40mg CII Rx Only1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UI24f766c1-f92b-4e48-b2f1-9d88b1b1be0c7
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use KALETRA safely and effectively. See full prescribing information for KALETRA. KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral use KALETRA (lopinavir and ritonavir) Solution for Oral use Initial U.S. Approval: 20001
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIULTRAM ® ER (tramadol HCl) Extended-Release Tablets1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIDrug Facts1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIFelodipine Extended-Release Tablets, USP Rx only1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use ACIPHEX safely and effectively. See full prescribing information for ACIPHEX. ACIPHEX (rabeprazole sodium) tablet, delayed release for oral use Initial U.S. Approval: 19992
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use ISENTRESS safely and effectively. See full prescribing information for ISENTRESS. ISENTRESS (raltegravir) Tablets Initial U.S. Approval: 20073
sodium stearyl fumarateINACTIVE INGREDIENT7CV7WJK4UIFexofenadine HCl and Pseudoephedrine HCl5
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIad682e7f-e0f5-4f11-8e05-dd308cbf6a051
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIPRAVASTATIN SODIUM TABLETS Rx only1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIThese highlights do not include all the information needed to use JANUVIA safely and effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) Tablets Initial U.S. Approval: 20063
Sodium Stearyl FumarateINACTIVE INGREDIENT7CV7WJK4UIOmeprazole Delayed Release Tablets, 20 mg1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOmeprazole Delayed Release Tablets, 20 mg1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIMetoprolol Succinate Extended-Release Tablets, USP 25 mg3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIMetoprolol Succinate Extended-Release Tablets, USP 50 mg3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIa5ca8004-9a18-4030-a56c-8938c4823c641
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIMetoprolol Succinate Extended-Release Tablets, USP 100 mg and 200 mg1
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIb951455c-c235-4e23-9e21-08672d1087262
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIea8ce5e2-dad4-4288-a1e1-775ea98a6fb94
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIONDANSETRON TABLET, ORALLY DISINTEGRATING [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3925
sodium stearyl fumarateINACTIVE INGREDIENT7CV7WJK4UIULTRAM ER (TRAMADOL HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3685
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIJANUVIA (SITAGLIPTIN) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3631
sodium stearyl fumarateINACTIVE INGREDIENT7CV7WJK4UIJANUMET (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3630
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLIES DBA QUALITY CARE PRODUCTS LLC]3607
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUTCS LLC]3575
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOPANA ER (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3165
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED KALETRA (LOPINAVIR AND RITONAVIR) SOLUTION [ABBVIE INC.]1567
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UINORVIR (RITONAVIR) TABLET, FILM COATED NORVIR (RITONAVIR) SOLUTION [ABBVIE INC.]1509
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UITRILIPIX (FENOFIBRIC ACID) CAPSULE, DELAYED RELEASE [ABBVIE INC.]1459
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UITARKA (TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ABBVIE INC.]1453
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIMAVIK (TRANDOLAPRIL) TABLET [ABBVIE INC.]1435
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIKALETRA (LOPINAVIR AND RITONAVIR) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]1405
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UICLARITHROMYCIN TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1003
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIACIPHEX (RABEPRAZOLE SODIUM) TABLET, COATED [BRYANT RANCH PREPACK]1001
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIFENOFIBRATE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIOXCARBAZEPINE TABLET, FILM COATED [BRYANT RANCH PREPACK]1001
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIFELODIPINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UIPLENDIL (FELODIPINE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UITOPROL XL (METOPROLOL SUCCINATE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UITOPROL XL (METOPROLOL SUCCINATE) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 7CV7WJK4UI page 1 of 1 · 17 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808CAPSULEORAL180 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808CAPSULE, DELAYED RELEASEORAL8.4 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808CAPSULE, EXTENDED RELEASEORAL21 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808GRANULEORAL77 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808GRANULE, FOR SOLUTIONORAL18.2 mg/120ml
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808LOZENGEORAL125 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808PELLETORAL43 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808POWDER, FOR SUSPENSIONORAL3.74 mg/5ml
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLETORAL153 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, CHEWABLEORAL28 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, COATEDORAL1.18 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, DELAYED RELEASEORAL216 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, EXTENDED RELEASEORAL42 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, FILM COATEDORAL98 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, FOR SUSPENSIONORAL435 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLET, ORALLY DISINTEGRATINGORAL153 mg
SODIUM STEARYL FUMARATE7CV7WJK4UI4070808TABLETSUBLINGUAL29 mg